Instil Bio Stock Alpha and Beta Analysis

TIL Stock  USD 29.70  4.27  16.79%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Instil Bio. It also helps investors analyze the systematic and unsystematic risks associated with investing in Instil Bio over a specified time horizon. Remember, high Instil Bio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Instil Bio's market risk premium analysis include:
Beta
4.83
Alpha
1.71
Risk
16.28
Sharpe Ratio
0.14
Expected Return
2.21
Please note that although Instil Bio alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Instil Bio did 1.71  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Instil Bio stock's relative risk over its benchmark. Instil Bio has a beta of 4.83  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Instil Bio will likely underperform. At this time, Instil Bio's Price Book Value Ratio is quite stable compared to the past year. Price Fair Value is expected to rise to 0.23 this year, although Book Value Per Share will most likely fall to 27.15.

Enterprise Value

138.11 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Instil Bio Backtesting, Instil Bio Valuation, Instil Bio Correlation, Instil Bio Hype Analysis, Instil Bio Volatility, Instil Bio History and analyze Instil Bio Performance.
For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.

Instil Bio Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Instil Bio market risk premium is the additional return an investor will receive from holding Instil Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Instil Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Instil Bio's performance over market.
α1.71   β4.83

Instil Bio expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Instil Bio's Buy-and-hold return. Our buy-and-hold chart shows how Instil Bio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Instil Bio Market Price Analysis

Market price analysis indicators help investors to evaluate how Instil Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Instil Bio shares will generate the highest return on investment. By understating and applying Instil Bio stock market price indicators, traders can identify Instil Bio position entry and exit signals to maximize returns.

Instil Bio Return and Market Media

The median price of Instil Bio for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 is 33.58 with a coefficient of variation of 46.51. The daily time series for the period is distributed with a sample standard deviation of 17.51, arithmetic mean of 37.64, and mean deviation of 13.91. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Heres Why Everyones Talking About Summit Therapeutics
09/17/2024
2
Acquisition by Bronson Crouch of 50000 shares of Instil Bio at 66.1 subject to Rule 16b-3
09/18/2024
3
Biosyngen Best-in-Class Next-Generation Tumor-Infiltrating Lymphocyte Technology Debuts on ESMO 2024 Annual Meeting
09/20/2024
4
Acquisition by Shah Nimish P of 10470 shares of Instil Bio at 20.0 subject to Rule 16b-3
10/21/2024
5
Summit Therapeutics Stock Sell or Hold Before Q3 Earnings
10/24/2024
6
Instil Bio, Inc.s stock price dropped 18 percent last week private equity firms would not be happy
11/04/2024
7
TILLADELSE TIL SPAREKASSENS THYS KB AF AKTIER
11/07/2024
8
Instil Bio GAAP EPS of -3.54
11/13/2024
9
Acquisition by Shah Nimish P of 430431 shares of Instil Bio subject to Rule 16b-3
11/21/2024
10
Acquisition by Shah Nimish P of 480716 shares of Instil Bio subject to Rule 16b-3
11/26/2024

About Instil Bio Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Instil or other stocks. Alpha measures the amount that position in Instil Bio has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 (projected)
Graham Number136.9395.37
Receivables Turnover0.03910.0348

Instil Bio Upcoming Company Events

As portrayed in its financial statements, the presentation of Instil Bio's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Instil Bio's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Instil Bio's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Instil Bio. Please utilize our Beneish M Score to check the likelihood of Instil Bio's management manipulating its earnings.
29th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Instil Bio

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Instil Bio is a strong investment it is important to analyze Instil Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instil Bio's future performance. For an informed investment choice regarding Instil Stock, refer to the following important reports:
Check out Instil Bio Backtesting, Instil Bio Valuation, Instil Bio Correlation, Instil Bio Hype Analysis, Instil Bio Volatility, Instil Bio History and analyze Instil Bio Performance.
For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Instil Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Instil Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Instil Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...